Trial Profile
13-valent pneumococcal conjugate vaccine (PCV13) administered concurrently with inactivated influenza vaccine for persons over 65 years
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 11 Jun 2018
Price :
$35
*
At a glance
- Drugs Influenza virus vaccine (Primary) ; Pneumococcal 13-valent CRM197 vaccine conjugate (Primary)
- Indications Influenza virus infections; Pneumococcal infections
- Focus Adverse reactions
- 11 Jun 2018 New trial record